JEFFREY E GERSHENWALD to Clinical Trials, Phase III as Topic
This is a "connection" page, showing publications JEFFREY E GERSHENWALD has written about Clinical Trials, Phase III as Topic.
Connection Strength
0.070
-
KEYNOTE-716: Phase III study of adjuvant pembrolizumab versus placebo in resected high-risk stage II melanoma. Future Oncol. 2020 Jan; 16(3):4429-4438.
Score: 0.037
-
Chemoprevention agents for melanoma: A path forward into phase 3 clinical trials. Cancer. 2019 01 01; 125(1):18-44.
Score: 0.034